SCHEMBL276599

SCHEMBL276599

Cc1ccc(OCC(=O)OC(C)(C)C)c(Cc2c(C)c(Cc3cc(C)c(OCC(=O)OC(C)(C)C)c(Cc4cc(C)ccc4OCC(=O)OC(C)(C)C)c3C)cc(C)c2OCC(=O)OC(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
HPGD P15428 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 3/20 0.37
TDP1 Q9NUW8 3/20 0.36
GAA P10253 1/20 0.36
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
MTNR1A P48039 3/20 0.34
MTNR1B P49286 3/20 0.34
MAPT P10636 3/20 0.33
NPC1 O15118 3/20 0.33
LMNA P02545 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23028315 0.93 ALDH1A1 (0.38) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL22504633 0.92 ALDH1A1 (0.36) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL19188818 0.89 KDM4E (0.43) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL8955291 0.85 KDM4E (0.42) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL13588056 0.76 KDM4E (0.43) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL12541603 0.76 MEN1 (0.52) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL1276578 0.75 KDM4E (0.42) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL8958295 0.75 HPGD (0.41) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL12227892 0.71 KDM4E (0.49) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL12227894 0.71 KDM4E (0.49) KDM4EHPGDALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11835849-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2023-12-05 US disclosed
US-11835849-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2023-12-05 US disclosed
US-20230194983-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2023-06-22 US disclosed
US-20230194983-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2023-06-22 US disclosed
US-8133653-B2 Positive resist composition for forming thick-film resist, thick-film resist laminate, and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2012-03-13 US disclosed
US-8133653-B2 Positive resist composition for forming thick-film resist, thick-film resist laminate, and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2012-03-13 US disclosed
US-20090023102-A1 POSITIVE RESIST COMPOSITION FOR FORMING THICK-FILM RESIST, THICK-FILM RESIST LAMINATE, AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD (JP) 2009-01-22 US disclosed
US-20090023102-A1 POSITIVE RESIST COMPOSITION FOR FORMING THICK-FILM RESIST, THICK-FILM RESIST LAMINATE, AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD (JP) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11835849-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device RER1, TERB1, TRRAP KDM4E 1886/4885HPGD 3822/4885ALDH1A1 2433/4885
US-20230194983-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE RER1, TERB1, TRRAP KDM4E 1921/4885HPGD 3878/4885ALDH1A1 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.